FDA Approved, HIV Confirmatory Test
Sanochemia´s Fluorognost IFA HIV-1 is the result of dedicated research and development since 1985. The US Food and Drug Administration (FDA) approved the assay in February 1992. Previously known as Waldheim IFA, Fluorognost IFA confirmatory test for HIV-1 allows laboratories to establish a definite status for samples that are positive or indeterminate by routine screening assays as a PRIMARY CONFIRMATION TEST for HIV-1 instead of western blot. Serum, plasma and dried blood spot (DBS)* eluates are all suitable substrates for testing. The assay is completed in 90 minutes, requires minimal amounts of sample, and provides an extremely high degree of accuracy. Fluorognost HIV-1 IFA is currently being used by many Public Health Laboratories, Blood Banks, Commercial Reference Laboratories and other labs performing HIV-1 testing in the US and Europe.
Find out yourself:
Push here for the TOP 10 reasons why to use Fluorognost IFA in your lab